These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2487549)

  • 1. The use of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Rouleau JL; Juneau C; de Champlain J
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):883-90. PubMed ID: 2487549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multifacetted role of angiotensin converting enzyme inhibitors in congestive heart failure.
    Firth BG
    Am J Med Sci; 1988 Oct; 296(4):275-88. PubMed ID: 3057910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE-inhibitors in coronary artery disease?
    Vogt M; Motz W; Strauer BE
    Basic Res Cardiol; 1993; 88 Suppl 1():43-64. PubMed ID: 8357335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal functional alterations induced by angiotensin-converting enzyme inhibitors in heart failure.
    Munger MA
    Ann Pharmacother; 1993 Feb; 27(2):205-10. PubMed ID: 8439700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of angiotensin-converting enzyme inhibition in congestive heart failure.
    Gottlieb SS; Weir MR
    Am J Cardiol; 1990 Oct; 66(11):14D-20D; discussion 20D-21D. PubMed ID: 2220600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS
    Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving role of angiotensin-converting enzyme inhibition in heart failure: expanding the protective envelope.
    Teerlink JR
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S32-7. PubMed ID: 7700062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure.
    McKelvie R; McConachie D; Yusuf S
    Eur Heart J; 1994 May; 15 Suppl B():9-13; discussion 26-30. PubMed ID: 8076660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure.
    Massie BM
    Am J Med; 1988 Apr; 84(4A):36-46. PubMed ID: 3064607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors: congestive heart failure and beyond.
    Lombardi WL; Litwin SE
    Coron Artery Dis; 1999 Sep; 10(6):361-8. PubMed ID: 10474785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of angiotensin-converting enzyme inhibition on coronary blood flow and infarct size limitation.
    Dargie HJ; Ray SG
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():101-6. PubMed ID: 2674435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations.
    Remme WJ
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):375-96. PubMed ID: 2487535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Captopril in the treatment of heart failure].
    Kékes E
    Acta Pharm Hung; 1997 Jul; 67(4):155-63. PubMed ID: 9289944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in angiotensin-converting enzyme inhibition in heart failure: rationale, mechanisms, and clinical responses.
    Dzau VJ; Creager MA
    Cardiol Clin; 1989 Feb; 7(1):119-30. PubMed ID: 2650868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
    Pitt B
    Cardiology; 1995; 86 Suppl 1():41-5. PubMed ID: 7614506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
    Marenzi G; Lauri G; Assanelli E; Grazi M; Guazzi M; Berna G; Salvioni A; Agostoni P
    Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.